Hyperfine, Inc. (HYPR)
NASDAQ: HYPR · Real-Time Price · USD
1.160
+0.090 (8.41%)
At close: Mar 9, 2026, 4:00 PM EDT
1.170
+0.010 (0.86%)
After-hours: Mar 9, 2026, 4:51 PM EDT
Hyperfine Market Cap
Hyperfine has a market cap or net worth of $112.72 million as of March 9, 2026. Its market cap has increased by 35.99% in one year.
Market Cap
112.72M
Enterprise Value
90.36M
1-Year Change
35.99%
Ranking
Category
Stock Price
$1.16
Market Cap Chart
Since January 27, 2021, Hyperfine's market cap has increased from $45.05M to $112.72M, an increase of 150.23%. That is a compound annual growth rate of 19.67%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 103.97M | 9.26% |
| Dec 31, 2025 | 95.16M | 48.23% |
| Dec 31, 2024 | 64.19M | -19.95% |
| Dec 29, 2023 | 80.19M | 35.27% |
| Dec 30, 2022 | 59.28M | -88.32% |
| Dec 31, 2021 | 507.73M | 1,027.17% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AVITA Medical | 145.50M |
| LENSAR | 140.95M |
| Apyx Medical | 128.01M |
| Baird Medical Investment Holdings | 113.85M |
| Neuronetics | 94.51M |
| Treace Medical Concepts | 92.13M |
| Xtant Medical Holdings | 86.80M |
| MaxCyte | 83.46M |